Charted
Wednesday, Nov. 18, 2026The business of health, by the numbers
Live trackersDeal tracker $7.07B raisedFDA clearances 293 510(k)s in OctoberForm D raises $839M in 30 daysNew trials 266 Phase 2/3 in 30 days

Biotech: IPOs

The financing and dealmaking behind drug development: rounds, IPOs, and acquisitions.

By the numbers

All trackers

Latest

That's all for IPOs so far. All Biotech stories